(PharmaNewsWire.Com, September 12, 2019 ) Market Overview: Nicotiana tabacum, the type of nicotine found in tobacco plants, comes from the nightshade family. While not cancer-causing or excessively harmful on its own, nicotine is massively addictive and exposes people to the extremely adverse effects of tobacco dependency and is one of the most commonly abused drugs.
Market Dynamics: The global market for the Smoking Cessation and Nicotine De-Addiction Therapeutics Market is primarily driven by the rising awareness about smoking health hazards such as increasing prevalence of cardiac diseases, respiratory disorders, and lung cancer stemming from smoking. However, the low awareness about smoking cessation products in developing economies and legal restrictions on the products may hinder the market progress.
Market Segmentation: By Product Type Nicotine Replacement Therapy Prescription Drug Therapy E-Cigarettes
It is also segmented on the basis of Distribution Channel.
Geographical Analysis: By Geography, the market is segmented into: North America Europe South America Asia Pacific The Middle East and Africa
Competitive Analysis: Key players: Johnson & Johnson Pfizer Novartis International AG GlaxoSmithKline Plc. Takeda Pharmaceuticals Cipla Ltd. Others
About Us DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information: Sai Kiran Sales Manager at Data M Intelligence Email: info@datamintelligence.com Tel: +1 877 441 4866 Website: www.datamintelligence.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
